Organisation paid for research Program year 2025 Source: CMS Open Payments

Doylestown Health

Neither a doctor nor a teaching hospital

Research payments

$272,276

68 payments

Through program year 2025, Doylestown Health is reported as receiving $272,276 in research payments, across 68 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$25,700	6
2024	Research	$38,038	4
2023	Research	$58,218	15
2022	Research	$44,877	15
2021	Research	$105,443	28

Breakdown

Who paid Research payments · program years 2021–2025

Medtronic, Inc. $195,527 40 payments
AstraZeneca Pharmaceuticals LP $36,074 2 payments
Bayer HealthCare Pharmaceuticals Inc. $34,879 19 payments
Daiichi Sankyo Inc. $5,796 7 payments

Studies the money was for Research payments · program years 2021–2025

Pulsed Af $129,280 23 payments
Tracking treatment pathways in adult patients with hyperkalemia (TRACK) $36,074 2 payments
SPHERE Per AF $25,947 10 payments
PulseSelect Registry $22,800 6 payments
A multicenter randomized double-blind parallel-group placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction = 40% (LVEF = 40%) $18,320 9 payments
Affera Global Registry $17,500 1 payment
BAY94-8862 LCM HFmr/pEF (EF 40%) $16,559 10 payments
Envisage $5,796 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.